Universal Health Services (UHS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
9 Jun, 2026Volume and demand trends
Acute volume growth for 2026 is expected in the 2%-3% range, with Q1 volumes at the low end after adjusting for flu and weather.
Significant Acute capacity was added in Q2, including 178 beds across three projects in Florida, Las Vegas, and California, expected to ramp quickly.
Cedar Hill Hospital in Washington, D.C. is expected to see higher volumes and earnings in the second half of the year.
Outpatient growth is emphasized, with plans to double or triple the number of ASCs and expand freestanding emergency departments.
Margin outlook and headwinds
Acute margins have nearly recovered to pre-COVID targets, reaching 15.8% on a same-store basis in 2025.
New headwinds include the end of exchange subsidies, Medicaid work requirements, and supplemental payment reductions starting in 2028.
Technology and AI investments are expected to offset some margin pressures, with 50 basis points of revenue per unit improvement in 2025.
AI and productivity initiatives
Over two dozen AI projects are active, including ER coding, denials management, and intake process automation.
AI-generated denial appeal letters and post-discharge calls have improved labor productivity and patient satisfaction.
AI is used to project and manage patient length of stay in real time, aiming for further reductions.
Labor productivity and efficiency gains are expected to be key multi-year margin drivers.
Latest events from Universal Health Services
- Q2 2026 net income rose to $358M on 8.3% higher revenues, with major acquisitions and Medicaid risks.UHS
Q2 20267 Aug 2026 - Strong 2025 results and 2026 growth outlook, with ongoing investment and managed regulatory risks.UHS
Q4 20259 Jul 2026 - Q2 2025 net income up 22% with strong revenue, margin gains, and higher EPS guidance amid Medicaid risks.UHS
Q2 20258 Jul 2026 - Q1 2025 net income rose 21% on 6.7% revenue growth, with strong segment performance.UHS
Q1 20258 Jul 2026 - Strong 2024 performance, margin recovery, and behavioral growth drive optimism despite policy headwinds.UHS
KeyBanc Annual Healthcare Forum 20258 Jul 2026 - Directors and auditors were approved; shareholder proposal on voting structure was rejected.UHS
AGM 202620 May 2026 - Revenue growth, operational expansion, and AI-driven efficiency shape a positive outlook.UHS
Bank of America Global Healthcare Conference 202618 May 2026 - Q1 2026 delivered strong growth, Talkspace acquisition, and Medicaid headwinds ahead.UHS
Q1 20267 May 2026 - Virtual annual meeting to vote on director, pay, auditor, and ESG-related proposals.UHS
Proxy filing9 Apr 2026